Date Filed | Type | Description |
06/12/2023 |
4
| GOEDDEL DAVID V (10% Owner) has filed a Form 4 on Tenaya Therapeutics, Inc.
Txns:
| Granted 29,532 options to buy
@ $7.12, valued at
$210.3k
|
|
05/12/2023 |
4
| GOEDDEL DAVID V (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns:
| Granted 78,407 options to buy
@ $3.69, valued at
$289.3k
|
|
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/25/2023 |
4
| GOEDDEL DAVID V (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns:
| Bought 9,900 shares
@ $4.9994, valued at
$49.5k
|
|
01/23/2023 |
4
| GOEDDEL DAVID V (10% Owner) has filed a Form 4 on Tenaya Therapeutics, Inc.
Txns:
| Bought 69,739 shares
@ $2.4979, valued at
$174.2k
|
|
01/23/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/19/2023 |
4
| GOEDDEL DAVID V (10% Owner) has filed a Form 4 on Tenaya Therapeutics, Inc.
Txns:
| Bought 49,463 shares
@ $2.4947, valued at
$123.4k
Bought 135,688 shares
@ $2.5163, valued at
$341.4k
|
|
01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/12/2023 |
4
| GOEDDEL DAVID V (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns:
| Bought 100,070 shares
@ $4.8418, valued at
$484.5k
Bought 209,000 shares
@ $4.76, valued at
$994.8k
|
|
12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/07/2022 |
4
| GOEDDEL DAVID V (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns:
| Bought 104,090 shares
@ $4.9871, valued at
$519.1k
Bought 35,058 shares
@ $4.7156, valued at
$165.3k
|
|
10/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/26/2022 |
4
| GOEDDEL DAVID V (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns:
| Bought 241,750 shares
@ $0 Bought 8,250 shares
@ $0 Bought 579,910 shares
@ $0 Bought 19,791 shares
@ $0 |
|
11/16/2021 |
4
| COLUMN GROUP II, LP (10% Owner) has filed a Form 4 on Oric Pharmaceuticals, Inc.
Txns:
| Disposed of 1,200,000 shares
@ $0 Acquired 287,702 shares
@ $0 Disposed of 287,702 shares
@ $0 Acquired 86,716 shares
@ $0 Acquired 86,716 shares
@ $0 Acquired 74 shares
@ $0 Exercised 16,625 options to buy
@ $16, valued at
$266k
|
|
|